| 51 |
16478794 | MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. | 2006 Mar |
2 |
| 52 |
16964701 | [Is MDR 1 gene a key to successful chemotherapy?]. | 2006 Jun |
1 |
| 53 |
15617835 | Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells. | 2005 Jan 20 |
3 |
| 54 |
15999103 | Combined effects of GSTP1 and MRP1 in melanoma drug resistance. | 2005 Jul 25 |
1 |
| 55 |
16023314 | A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay. | 2005 Sep 14 |
1 |
| 56 |
14726695 | Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein. | 2004 Apr |
1 |
| 57 |
15049699 | Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation. | 2004 Apr 6 |
2 |
| 58 |
15590186 | Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. | 2004 Dec 1 |
2 |
| 59 |
12948018 | Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. | 2003 Aug |
1 |
| 60 |
11901101 | Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). | 2002 Apr |
1 |
| 61 |
12516967 | Identification and characterization of the canine multidrug resistance-associated protein. | 2002 Dec |
1 |
| 62 |
11284689 | Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein. | 2001 Apr 10 |
1 |
| 63 |
11473730 | A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells. | 2001 Jul |
1 |
| 64 |
11486401 | DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL). | 2001 Jul |
1 |
| 65 |
11504821 | Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. | 2001 Sep |
4 |
| 66 |
11595714 | In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line. | 2001 Oct |
2 |
| 67 |
10747957 | Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. | 2000 Jun 9 |
3 |
| 68 |
10755319 | Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance. | 2000 |
3 |
| 69 |
10912951 | Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. | 2000 Jun |
3 |
| 70 |
9864431 | The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line. | 1999 Jan-Feb |
6 |
| 71 |
10233413 | Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL. | 1999 May |
1 |
| 72 |
10561359 | Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. | 1999 Sep |
1 |
| 73 |
10576649 | The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. | 1999 Nov |
2 |
| 74 |
9485370 | Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. | 1998 Feb 24 |
1 |
| 75 |
9504636 | MDR1 gene expression and drug resistance of AML cells. | 1998 Mar |
2 |
| 76 |
9649010 | Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers. | 1998 Jun |
1 |
| 77 |
9652763 | Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer. | 1998 May |
1 |
| 78 |
9685354 | Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. | 1998 Aug 7 |
1 |
| 79 |
9780138 | Therapeutic approach to drug resistant tumors. | 1998 Oct |
1 |
| 80 |
9155147 | [Multidrug resistance of cancer cells mediated by ABC superfamily transporters]. | 1997 May |
1 |
| 81 |
9220975 | Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. | 1997 Jul 22 |
1 |
| 82 |
9272128 | Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. | 1997 |
1 |
| 83 |
9272134 | Treatment for adult T-cell leukemia. | 1997 |
1 |
| 84 |
9350240 | [Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines]. | 1997 Oct |
1 |
| 85 |
9353133 | P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells. | 1997 Oct 1 |
2 |
| 86 |
9377550 | Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. | 1997 Oct 15 |
1 |
| 87 |
9639738 | [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma]. | 1997 Aug |
1 |
| 88 |
8567633 | Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. | 1996 Jan 26 |
1 |
| 89 |
8612315 | Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. | 1996 |
1 |
| 90 |
8640766 | Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). | 1996 Mar 1 |
1 |
| 91 |
9042212 | Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. | 1996 Nov-Dec |
1 |
| 92 |
7492789 | Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors. | 1995 Dec 1 |
1 |
| 93 |
7670142 | Development of drug resistance is reduced with idarubicin relative to other anthracyclines. | 1995 Jun |
1 |
| 94 |
7834606 | Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. | 1995 Feb 1 |
1 |
| 95 |
7705462 | Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. | 1994 Dec 15 |
2 |
| 96 |
7914749 | Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal. | 1994 |
1 |
| 97 |
8028036 | Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. | 1994 Aug 3 |
1 |
| 98 |
8070020 | Etoposide: current status and future perspectives in the management of malignant neoplasms. | 1994 |
2 |
| 99 |
8100862 | Evaluation of multiple drug resistance in human bladder cancer cell lines. | 1993 Aug |
1 |
| 100 |
8106148 | Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin. | 1993 Nov 15 |
1 |